104 related articles for article (PubMed ID: 6298933)
41. Clinical studies of sucralfate in reflux esophagitis. The European experience.
Hameeteman W
J Clin Gastroenterol; 1991; 13 Suppl 2():S16-20. PubMed ID: 1885899
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitidine for treatment of patients with moderate to severe erosive esophagitis. Famotidine Erosive Esophagitis Study Group.
Simon TJ; Berlin RG; Tipping R; Gilde L
Scand J Gastroenterol; 1993 May; 28(5):375-80. PubMed ID: 8511496
[TBL] [Abstract][Full Text] [Related]
43. Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment.
Oh TY; Lee JS; Ahn BO; Cho H; Kim WB; Kim YB; Surh YJ; Cho SW; Hahm KB
Free Radic Biol Med; 2001 Apr; 30(8):905-15. PubMed ID: 11295533
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the effect of sucralfate and ranitidine in reflux esophagitis.
Simon B; Mueller P
Am J Med; 1987 Sep; 83(3B):43-7. PubMed ID: 3310628
[TBL] [Abstract][Full Text] [Related]
45. Reflux esophagitis therapy: sucralfate versus ranitidine in a double blind multicenter trial.
Bremner CG; Marks IN; Segal I; Simjee A
Am J Med; 1991 Aug; 91(2A):119S-122S. PubMed ID: 1882897
[TBL] [Abstract][Full Text] [Related]
46. [Medical and surgical trends in the treatment of peptic ulcer: importance of clinico-endoscopic preselection and follow-up].
Mirelli E; De Marzo V; Siardi C; Bozzolo P
Clin Ter; 1982 Jul; 102(1):3-13. PubMed ID: 6128097
[No Abstract] [Full Text] [Related]
47. [H2-blockers in reflux-esophagitis].
Berstad A
Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1439-41. PubMed ID: 6138879
[No Abstract] [Full Text] [Related]
48. [Treatment with ranitidine in reflux esophagitis].
Balanzoni S; Bagioni P; Turicchia GU; Campagnoni R; Sansone G; Tampieri I
Minerva Dietol Gastroenterol; 1986; 32(1):35-8. PubMed ID: 3703318
[No Abstract] [Full Text] [Related]
49. [Ranitidine--what will the future bring].
Rösch W
Fortschr Med; 1982 Dec; 100(45):2096-8. PubMed ID: 6293949
[No Abstract] [Full Text] [Related]
50. Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150 mg bid and 300 mg bid.
Hegarty JH; Halvorsen L; Hazenberg BP; Nowak A; Smith CL; Thomson AB; Vantrappen G; McKenna CJ; Mills JG
Can J Gastroenterol; 1997; 11(1):83-8. PubMed ID: 9113805
[TBL] [Abstract][Full Text] [Related]
51. Long-term therapy for reflux esophagitis.
Tytgat GN
N Engl J Med; 1995 Oct; 333(17):1148-50. PubMed ID: 7565956
[No Abstract] [Full Text] [Related]
52. [Therapy of esophageal reflux disease].
Rösch W
Dtsch Med Wochenschr; 1982 Mar; 107(10):389-91. PubMed ID: 6277588
[No Abstract] [Full Text] [Related]
53. Sucralfate in the treatment of reflux esophagitis in adults: an update.
Simon B; Dammann HG; Müller P
Scand J Gastroenterol Suppl; 1989; 156():37-41. PubMed ID: 2662389
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of sucralfate in refractory reflux esophagitis. Results of a pilot study.
Ros E; Pujol A; Bordas JM; Grande L
Scand J Gastroenterol Suppl; 1989; 156():49-55. PubMed ID: 2740842
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis.
Wesdorp IC; Dekker W; Festen HP
Dig Dis Sci; 1993 Dec; 38(12):2287-93. PubMed ID: 8261835
[TBL] [Abstract][Full Text] [Related]
56. Treatment of reflux esophagitis with histamine H2-receptor antagonists.
Kishi S; Tsuzi Y; Matsumura M; Kakutani A; Ito S; Mori H
Tokushima J Exp Med; 1985 Dec; 32(3-4):65-70. PubMed ID: 2875547
[No Abstract] [Full Text] [Related]
57. [Etintidine versus ranitidine in the treatment of reflux esophagitis].
Wienbeck M; Rohner HG; Hüttemann W; Pelz W
Dtsch Med Wochenschr; 1986 Sep; 111(39):1501-2. PubMed ID: 3757813
[No Abstract] [Full Text] [Related]
58. Is body mass index really the most important factor determining the healing of reflux esophagitis by esomeprazole?
Lo GH
Am J Gastroenterol; 2009 Mar; 104(3):787; author reply 787-8. PubMed ID: 19240701
[No Abstract] [Full Text] [Related]
59. [Predictive factors for healing of esophagitis. Prospective study during ranitidine therapy].
Fournet J; Ottignon Y; Alberola B
Presse Med; 1993 Jun; 22(23):1087-90. PubMed ID: 8415460
[TBL] [Abstract][Full Text] [Related]
60. Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis.
Fielding JF; Doyle GD
Ir Med J; 1984 Nov; 77(11):356-7. PubMed ID: 6096296
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
